acetylcysteine has been researched along with Depression, Involutional in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| di Michele, F; Niolu, C; Siracusano, A; Talamo, A | 1 |
| Iwata, N; Kishi, T; Miyake, N; Okuya, M; Sakuma, K | 1 |
| Andrade, C | 1 |
| Colpo, GD; Dantzer, R; Leboyer, M; Teixeira, AL; Trivedi, MH | 1 |
| Berk, M; Cai, DB; Ng, CH; Ning, YP; Qiu, Y; Ungvari, GS; Xiang, YT; Yang, XH; Zhang, QE; Zheng, W | 1 |
| Bosker, FJ; Li, J; Schoevers, RA; Yang, C | 1 |
| Allwang, C; Berk, M; Bush, AI; Cobb, H; Cotton, SM; Dean, OM; Dodd, S; Hewitt, K; Jeavons, S; Kohlmann, K; Malhi, GS; Moss, K; Ng, F; Robbins, J; Schapkaitz, I; Tanious, M | 1 |
| Berk, M; Das, P; Dean, OM; Dodd, S; Fritz, K; Malhi, GS; Tanious, M | 1 |
4 review(s) available for acetylcysteine and Depression, Involutional
| Article | Year |
|---|---|
Vitamin D and N-Acetyl Cysteine Supplementation in Treatment-Resistant Depressive Disorder Patients: A General Review.
Topics: Acetylcysteine; Aged; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dietary Supplements; Humans; Vitamin D | 2020 |
N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
Topics: Acetylcysteine; Adult; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Immune-based strategies for mood disorders: facts and challenges.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Bipolar Disorder; Cytokines; Depressive Disorder, Major; Exercise Therapy; Fatty Acids, Unsaturated; Humans; Inflammation; Mesenchymal Stem Cell Transplantation; Mood Disorders; Neuroimmunomodulation; Probiotics | 2018 |
N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials.
Topics: Acetylcysteine; Antioxidants; Bipolar Disorder; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Schizophrenia | 2018 |
3 trial(s) available for acetylcysteine and Depression, Involutional
| Article | Year |
|---|---|
N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
Topics: Acetylcysteine; Adult; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diffusion Tensor Imaging; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Inflammation; Inflammation Mediators; Male; Oxidative Stress; Psychotherapy; Treatment Outcome | 2018 |
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Satisfaction; Surveys and Questionnaires | 2014 |
Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
Topics: Acetylcysteine; Aspartic Acid; Depressive Disorder, Major; Double-Blind Method; Female; Free Radical Scavengers; Functional Neuroimaging; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Oxidative Stress | 2013 |
1 other study(ies) available for acetylcysteine and Depression, Involutional
| Article | Year |
|---|---|
N-Acetylcysteine Augmentation for Patients With Major Depressive Disorder and Bipolar Depression.
Topics: Acetylcysteine; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Outcome Assessment, Health Care; Tranquilizing Agents | 2021 |